SCHEMBL476685

SCHEMBL476685

O=S(=O)(O)c1ccc(P(c2ccc(S(=O)(=O)O)cc2)c2ccc(S(=O)(=O)O)cc2)cc1.[Na]

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.59
ALDH1A1 P00352 6/20 0.56
TSHR P16473 3/20 0.56
NT5E P21589 1/20 0.56
SMN1; SMN2 Q16637 2/20 0.55
TDP1 Q9NUW8 4/20 0.50
POLB P06746 1/20 0.46
CYP2D6 P10635 1/20 0.46
HSD17B10 Q99714 4/20 0.41
KDM4E B2RXH2 3/20 0.41
ESR1 P03372 2/20 0.39
ESR2 Q92731 2/20 0.39
NAPRT Q6XQN6 1/20 0.38
HPGD P15428 1/20 0.38
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA14 Q9ULX7 1/20 0.36
CYP2C9 P11712 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL596057 1.00 LMNA (0.59) LMNAALDH1A1TSHRNT5ESMN1; SMN2
Sulfuric Acid SCHEMBL28088103 0.97 LMNA (0.56) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL28966026 0.97 LMNA (0.56) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL28966023 0.97 LMNA (0.56) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL28966024 0.97 LMNA (0.56) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL28229405 0.97 LMNA (0.56) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL28966025 0.97 LMNA (0.56) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL996850 0.91 TSHR (0.65) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL718256 0.91 TSHR (0.65) LMNAALDH1A1TSHRNT5ESMN1; SMN2
SCHEMBL301148 0.89 TSHR (0.62) LMNAALDH1A1TSHRNT5ESMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2410857-A1 P2X3, RECEPTOR ANTAGONISTS FOR TREATMENT OF PAIN Merck Sharp & Dohme Corp. (US) 2012-02-01 EP disclosed
US-6103908-A HYDROFORMYLATION CATALYSTS; SIMPLIFICATION, EFFICIENCY CELANESE GMBH (DE) 2000-08-15 US disclosed